Perinatal death or severe morbidity · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal or neonatal mortality · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in fetal or neonatal mortality compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Caesarean section · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Apgar score less than 7 at 5 minutes · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in 5‐minute Apgar score < 7 compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Low umbilical artery pH (< 7.2 or as defined by trial authors) · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in umbilical artery pH < 7.2 compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Abnormal FHR as defined by trial authors (FHR tracing not improved) · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline probably leads to lower FHR tracing not improved compared with no tocolytic agent, whilst awaiting emergency delivery (moderate certainty).
1 finding from 1 review
Apgar score less than 7 at 5 minutes · women with severe intrapartum fetal bradycardia
1 finding from 1 review
Umbilical artery pH · women with severe intrapartum fetal bradycardia
1 finding from 1 review
Abnormal FHR tracing · women with severe intrapartum fetal bradycardia
It is very uncertain whether summary of findings for IV atosiban changes abnormal FHR tracing compared with IV hexoprenaline (very low certainty).
1 finding from 1 review
Perinatal death or severe morbidity · women with severe intrapartum fetal bradycardia
Summary of findings for IV atosiban showed no clear difference in perinatal death or severe morbidity compared with IV hexoprenaline (low certainty).
1 finding from 1 review
Fetal or neonatal mortality · women with severe intrapartum fetal bradycardia
1 finding from 1 review
Caesarean section · women with severe intrapartum fetal bradycardia
Summary of findings for IV atosiban showed no clear difference in caesarean delivery compared with IV hexoprenaline (low certainty).
1 finding from 1 review